Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAquis Exchange Regulatory News (AQX)

Share Price Information for Aquis Exchange (AQX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 465.00
Bid: 460.00
Ask: 470.00
Change: -3.00 (-0.65%)
Spread: 10.00 (2.174%)
Open: 465.00
High: 462.00
Low: 462.00
Prev. Close: 465.00
AQX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

14 Jun 2018 08:30

RNS Number : 3412R
Aquis Exchange PLC
14 June 2018
 

Aquis Exchange PLC ("Aquis")

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Following the announcement of the admission of Aquis' ordinary shares of 10p each ("Ordinary Shares") to trading on the AIM market of the London Stock Exchange ("Admission") and Aquis' first day of dealings, Aquis confirms the following interests of its persons discharging managerial responsibilities ("PDMR") in the securities of Aquis arising by virtue of Admission.

As disclosed in its Admission Document, details of all known interests currently held by PDMRs in the issued share capital of Aquis as at Admission are as follows:

Name

Position

Number of Ordinary Shares

Number of Ordinary Shares over which options are granted following Admission

Alasdair Haynes

Chief Executive Officer

1,551,551

120,817

Jonathan Clelland

Chief Financial Officer, Chief Operating Officer and Company Secretary

576,000

120,817

Mark Spanbroek

Non-executive director

319,128

-

 

A. Exercise of Options

Prior to Admission, Jonathan Clelland chose to exercise options pursuant to an existing Enterprise Management Incentive Scheme (where the grantor was Alasdair Haynes) (the "Lapsing Incentive Scheme"). If these options were not exercised, they would have lapsed 40 days after Admission.

The exercise of the following options pursuant to the Lapsing Incentive Scheme took place on the date of Admission:

Name

Number of Ordinary Shares

subject to the option

Exercise Price per Ordinary Share

Jonathan Clelland

57,600

 

£0.0846354167 GBP

288,000

 

£0.1354166667 GBP

145,920

 

£0.2890625000 GBP

 

B. Grant of options

Ahead of Admission, the Board approved the grant of options under the new Aquis Exchange Enterprise Management Incentive Share Option Plan. The grant was approved conditional on Admission. The grant has been made on the date of Admission to the following PDMRs:

 

 

Name

Number of Ordinary Shares

subject to the option

Exercise Price per Ordinary Share

Jonathan Clelland

120,817

£2.69 GBP

Alasdair Haynes

120,817

£2.69 GBP

These options will vest in tranches of one third on each of the 14 June 2019, 14 June 2020 and 14 June 2021, subject to the rules of the plan, and may be exercised prior to 14 June 2028.

C. Sale of Shares 

As disclosed in the Admission Document, on Admission, the following disposals of Ordinary Shares were made by the following PDMRs at the IPO placing price of £2.69:

Name

Number of Ordinary Shares

sold

Jonathan Clelland

99,840

Alasdair Haynes

258,240

 

The attached notifications, made in accordance with requirements of the EU Market Abuse Regulation, give further details of the above transactions.

 

ENQUIRIES

Aquis Exchange PLC

Alasdair Haynes, CEO

Jonathan Clelland, CFO and COO

 

Tel: +44 (0) 20 3597 6321

Liberum Capital Limited (Nominated Adviser and Broker)

Clayton Bush

Chris Clarke

Jill Li

Kane Collings

 

Tel: +44 (0) 20 3100 2000

Finsbury (Financial Public Relations)

Alastair Hetherington

Michael Turner

Alexander Gorokhov

Tel: +44 (0) 20 7251 3801

Website:

http://www.aquis.eu

A. Transaction notification - Exercise of Options

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Jonathan Clelland

2.

Reason for the notification

a)

Position / status

Director (Chief Financial Officer, Chief Operations Officer, Company Secretary) - PDMR

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Aquis Exchange PLC

b)

213800IXJSF5E1SIW150

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification Code

Exercise of Enterprise Management Incentive share options over Ordinary Shares

GB00BD5JNK30

b)

Nature of the transaction

Exercise of Enterprise Management Incentive ("EMI") options under the Aquis Exchange Limited Enterprise Management Incentive Scheme (adopted pre-Admission)

c)

Price(s) and volume(s)

 

 

 

Price(s) per share (to 10 decimal places)

Volume(s)

£0.0846354167 GBP

£0.1354166667 GBP

£0.2890625000 GBP

57,600

288,000

145,920

d)

Aggregated information

- Aggregated volume

- Price

 

- 491,520

- £86,055 GBP

e)

Date of the transaction

2018-06-14 BST

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

B. Transaction notifications - Grant of options

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Jonathan Clelland

2.

Reason for the notification

a)

Position / status

Director (Chief Financial Officer, Chief Operations Officer, Company Secretary) - PDMR

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Aquis Exchange PLC

b)

LEI

213800IXJSF5E1SIW150

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification Code

Enterprise Management Incentive share options over Ordinary Shares

GB00BD5JNK30

b)

Nature of the transaction

Grant of Enterprise Management Incentive ("EMI") options under the Aquis Exchange Limited Enterprise Management Incentive Share Option Plan

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

£2.69 GBP

120,817

d)

Aggregated information

- Aggregated volume

- Price

 

- N/A

- £2.69 GBP

e)

Date of the transaction

2018-06-14 BST

f)

Place of the transaction

Outside a trading venue

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Alasdair Haynes

2.

Reason for the notification

b)

Position / status

Director (Chief Executive Officer) - PDMR

c)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Aquis Exchange PLC

b)

LEI

213800IXJSF5E1SIW150

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification Code

Enterprise Management Incentive share options over Ordinary Shares

GB00BD5JNK30

b)

Nature of the transaction

Grant of Enterprise Management Incentive ("EMI") options under the Aquis Exchange Limited Enterprise Management Incentive Share Option Plan

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

£2.69 GBP

120,817

d)

Aggregated information

- Aggregated volume

- Price

 

- N/A

- £2.69 GBP

e)

Date of the transaction

2018-06-14 BST

f)

Place of the transaction

Outside a trading venue

 

C. Transaction notification - Sale of ordinary shares

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Alasdair Haynes

2.

Reason for the notification

b)

Position / status

Director (Chief Executive Officer) - PDMR

c)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Aquis Exchange PLC

b)

LEI

213800IXJSF5E1SIW150

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification Code

Ordinary Shares

 

 

GB00BD5JNK30

 

b)

Nature of the transaction

Disposal of Ordinary Shares

c)

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

 

£2.69 GBP

 

258,240

d)

Aggregated information

- Aggregated volume

- Price

 

 

258,240

 

£2.69GBP

e)

Date of the transaction

2018-06-14 BST

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Jonathan Clelland

2.

Reason for the notification

b)

Position / status

Director (Chief Financial Officer) - PDMR

c)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Aquis Exchange PLC

b)

LEI

213800IXJSF5E1SIW150

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification Code

Ordinary Shares

 

 

GB00BD5JNK30

b)

Nature of the transaction

 

Disposal of Ordinary Shares

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£2.69GBP

 

99,840

 

d)

Aggregated information

- Aggregated volume

- Price

 

 

99,840

£2.69GBP

e)

Date of the transaction

2018-06-14 BST

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLFFSLRDIVLIT
Date   Source Headline
18th Apr 20242:30 pmRNSResult of AGM and Confirmation of Board Change
22nd Mar 20247:00 amRNSPublication of Annual Report and Notice of AGM
21st Mar 20247:00 amRNSResults for the year ended 31 December 2023
13th Mar 20247:00 amRNSContract with the Central Bank of Colombia
12th Mar 20247:00 amRNSAquis to Establish New Real Assets Market Segment
26th Feb 20247:00 amRNSAquis launches conditional order functionality
23rd Feb 20247:00 amRNSNotice of Results and Investor Presentation
25th Jan 20247:00 amRNSTrading Update and Notice of Results
23rd Jan 20243:15 pmRNSExercise of Share Options and Total Voting Rights
21st Dec 20231:15 pmRNSDirector/PDMR Notification
29th Nov 20237:00 amRNSAQSE becomes first cloud-based RIE
24th Nov 202312:00 pmRNSDirector/PDMR Notification
2nd Nov 20237:00 amRNSHolding(s) in Company
31st Oct 202311:55 amRNSBoard Change
18th Oct 20237:00 amRNSDirector/PDMR Shareholding
17th Oct 202312:39 pmRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSInterim Results
12th Sep 20237:00 amRNSAquis Markets - Change to Proprietary Trading Rule
7th Sep 20237:00 amRNSNotice of Results and Investor Presentation
6th Sep 20237:00 amRNSAppointment of Nominated Adviser and Joint Broker
7th Aug 20232:15 pmRNSAcquisition of Minority Interest
28th Jun 20237:00 amRNSDirector/PDMR Shareholding
6th Jun 20237:00 amRNSDirector/PDMR Shareholding
6th Jun 20237:00 amRNSAquis launches Dark to Lit Sweep
27th Apr 20237:00 amRNSDirector/PDMR Notification and Issue of Options
25th Apr 20232:18 pmRNSResult of AGM
14th Apr 20237:00 amRNSPublication of Annual Report & Notice of AGM
6th Apr 20231:05 pmRNSHolding(s) in Company
4th Apr 20237:00 amRNSDirector/PDMR Shareholding
3rd Apr 202310:55 amRNSDirector/PDMR Shareholding
3rd Apr 20237:01 amRNSDirector/PDMR Shareholdings
3rd Apr 20237:00 amRNSAquis Launches The World’s First 24x7 Exchange
30th Mar 20237:00 amRNSFinal Results
22nd Feb 20237:00 amRNSNotice of Results and Investor Presentation
2nd Feb 20237:00 amRNSExercise of Share Options & Total Voting Rights
2nd Feb 20237:00 amRNSExercise of Share Options & Total Voting Rights
26th Jan 20237:00 amRNSTrading Update and Notice of Results
5th Jan 20237:00 amRNSDirectorate Change
12th Dec 20227:00 amRNSIG Expands UK Trading Offering With AQSE Stocks
24th Nov 20229:13 amRNSDirector/PDMR Notification
23rd Nov 20224:09 pmRNSDirector/PDMR Notification
2nd Nov 20227:00 amRNSNotice of Capital Markets Day
27th Sep 20227:00 amRNSNotice of Capital Markets Day
22nd Sep 20227:00 amRNSInterim Results
5th Sep 202212:00 pmRNSLaunch of new EU dark pool, Aquis Matching Pool
23rd Aug 20227:00 amRNSNotice of Results
6th Jul 202212:00 pmRNSAPEX stocks now trading on Hargreaves Lansdown
30th Jun 202212:49 pmRNSDirector/PDMR Notification and Issue of Options
23rd Jun 20227:00 amRNSDirector/PDMR Shareholding
22nd Jun 202212:30 pmRNSExercise of Share Options and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.